Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting.

MLA

Bharwani, K. D., et al. “Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting.” Mediators of Inflammation, vol. 2020, Sept. 2020, p. 6259064. EBSCOhost, https://doi.org/10.1155/2020/6259064.

APA

Bharwani, K. D., Dirckx, M., Stronks, D. L., Dik, W. A., & Huygen, F. J. P. M. (2020). Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting. Mediators of Inflammation, 2020, 6259064. https://doi.org/10.1155/2020/6259064

Chicago

Bharwani, K D, M Dirckx, D L Stronks, W A Dik, and F J P M Huygen. 2020. “Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting.” Mediators of Inflammation 2020 (September): 6259064. doi:10.1155/2020/6259064.